row_id,panel,cell_line,value_raw,qualifier,value,unit,provenance_file,provenance_sheet,provenance_row
1,방광암세포주,253J,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,5637,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,전립선암세포주,CWR22,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,DLD-1,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,전립선암세포주,DU145,1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,전립선암세포주,DU145/TXR,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,HCT 116,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,HL-60,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,KU-19-19,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,흑색종,LOX-IMVI,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,MBT-2,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,MIA PaCa-2,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,MOLT-4,1.85 μM,=,1.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,MRC-5,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,MV-4-11,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,NCI-H12 99,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,NCI-H23,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,난소암,OVCAR-3,0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,전립선암세포주,PC-3,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,유방암세포주,SK-BR-3,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,간암세포주,SK-HEP-1,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,T24,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
1,방광암세포주,UM-UC-3,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
2,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
3,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,253J,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,5637,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,A549,1.97 μM,=,1.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,전립선암세포주,CWR22,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,DLD-1,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,전립선암세포주,DU145,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,전립선암세포주,DU145/TXR,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,HCT 116,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,HCT-15,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,HCT-8,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,HL-60,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,Jurkat,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,KU-19-19,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,흑색종,LOX-IMVI,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,LoVo,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,MBT-2,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,MIA PaCa-2,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,MOLT-4,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,MRC-5,0.91 μM,=,0.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,MV-4-11,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,NCI-H12 99,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,NCI-H1437,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,NCI-H23,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,NCI-H460,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,난소암,OVCAR-3,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,전립선암세포주,PC-3,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,RKO,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,Raji,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,Ramos (RA 1),1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,유방암세포주,SK-BR-3,0.91 μM,=,0.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,간암세포주,SK-HEP-1,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,대장암세포주,SW620,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,T24,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,뇌암세포주,U-138 MG,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,뇌암세포주,U-251 MG,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,혈액암세포주,U-937,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
4,방광암세포주,UM-UC-3,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
5,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,253J,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,5637,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,전립선암세포주,CWR22,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,DLD-1,0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,전립선암세포주,DU145,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,전립선암세포주,DU145/TXR,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,HCT 116,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,HCT-15,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,HL-60,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,흑색종,LOX-IMVI,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,MBT-2,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,MIA PaCa-2,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,MOLT-4,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,MV-4-11,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,NCI-H12 99,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,NCI-H23,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,난소암,OVCAR-3,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,전립선암세포주,PC-3,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,RKO,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,유방암세포주,SK-BR-3,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,간암세포주,SK-HEP-1,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,대장암세포주,SW620,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,T24,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
6,방광암세포주,UM-UC-3,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
7,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
8,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,253J,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,5637,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,전립선암세포주,CWR22,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,DLD-1,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,전립선암세포주,DU145,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,전립선암세포주,DU145/TXR,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,Daudi,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,HCT 116,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,HCT-15,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,HCT-8,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,HL-60,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,Jurkat,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,KU-19-19,1.97 μM,=,1.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,흑색종,LOX-IMVI,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,MBT-2,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,MIA PaCa-2,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,MOLT-4,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,MV-4-11,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,NCI-H12 99,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,NCI-H23,0.90 μM,=,0.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,난소암,OVCAR-3,0.58 μM,=,0.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,전립선암세포주,PC-3,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,RKO,1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,Raji,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,Ramos (RA 1),1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,유방암세포주,SK-BR-3,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,간암세포주,SK-HEP-1,0.99 μM,=,0.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,SW48 0,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,대장암세포주,SW620,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,T24,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,뇌암세포주,U-138 MG,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,혈액암세포주,U-937,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
9,방광암세포주,UM-UC-3,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
10,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,253J,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,DLD-1,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,전립선암세포주,DU145/TXR,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,NCI-H23,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,T24,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
11,방광암세포주,UM-UC-3,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
12,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
13,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
14,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,전립선암세포주,DU145/TXR,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,KU-19-19,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,MIA PaCa-2,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,NCI-H23,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,유방암세포주,SK-BR-3,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
15,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
16,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
17,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
18,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
19,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,NCI-H12 99,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,NCI-H1437,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,NCI-H23,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,NCI-H460,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,Raji,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,Ramos (RA 1),1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
20,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
21,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
22,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
23,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
24,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,유방암세포주,SK-BR-3,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
25,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,5637,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,Jurkat,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,MOLT-4,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,RKO,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,뇌암세포주,T98G,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
26,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
27,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,253J,0.74 μM,=,0.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,5637,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,전립선암세포주,CWR22,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,DLD-1,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,전립선암세포주,DU145,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,전립선암세포주,DU145/TXR,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,Daudi,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,HCT 116,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,HCT-15,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,HCT-8,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,HL-60,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,J82,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,Jurkat,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,KU-19-19,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,전립선암세포주,LNcap,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,흑색종,LOX-IMVI,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,LoVo,1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,MBT-2,0.79 μM,=,0.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,MDA-MB-231,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,MIA PaCa-2,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,MOLT-4,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,MRC-5,0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,MV-4-11,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,NCI-H12 99,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,NCI-H23,0.75 μM,=,0.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,NCI-H460,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,폐암세포주,NCI-H522,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,난소암,OVCAR-3,0.69 μM,=,0.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,전립선암세포주,PC-3,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,RKO,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,Raji,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,Ramos (RA 1),1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,유방암세포주,SK-BR-3,0.66 μM,=,0.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,간암세포주,SK-HEP-1,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,SW48 0,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,대장암세포주,SW620,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,T24,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,뇌암세포주,U-138 MG,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,뇌암세포주,U-251 MG,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,혈액암세포주,U-937,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
28,방광암세포주,UM-UC-3,0.79 μM,=,0.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,253J,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,5637,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,전립선암세포주,CWR22,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,DLD-1,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,전립선암세포주,DU145,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,전립선암세포주,DU145/TXR,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,HCT 116,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,HCT-15,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,HCT-8,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,HL-60,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,Jurkat,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,KU-19-19,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,전립선암세포주,LNcap,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,흑색종,LOX-IMVI,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,MBT-2,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,MIA PaCa-2,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,MOLT-4,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,MV-4-11,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,NCI-H12 99,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,NCI-H23,0.91 μM,=,0.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,NCI-H460,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,난소암,OVCAR-3,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,전립선암세포주,PC-3,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,RKO,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,Raji,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,Ramos (RA 1),1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,유방암세포주,SK-BR-3,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,간암세포주,SK-HEP-1,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,대장암세포주,SW620,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,T24,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,뇌암세포주,U-138 MG,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,뇌암세포주,U-251 MG,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,혈액암세포주,U-937,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
29,방광암세포주,UM-UC-3,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
30,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,253J,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,5637,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,A549,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,전립선암세포주,CWR22,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,DLD-1,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,전립선암세포주,DU145,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,전립선암세포주,DU145/TXR,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,Daudi,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,HCT 116,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,HCT-15,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,HCT-8,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,HL-60,1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,J82,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,Jurkat,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,KU-19-19,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,전립선암세포주,LNcap,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,흑색종,LOX-IMVI,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,MBT-2,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,MDA-MB-231,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,MIA PaCa-2,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,MOLT-4,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,NCI-H12 99,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,NCI-H23,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,NCI-H460,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,난소암,OVCAR-3,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,전립선암세포주,PC-3,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,RKO,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,Raji,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,Ramos (RA 1),1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,유방암세포주,SK-BR-3,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,간암세포주,SK-HEP-1,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,SW48 0,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,대장암세포주,SW620,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,T24,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,뇌암세포주,U-138 MG,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,뇌암세포주,U-251 MG,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
31,방광암세포주,UM-UC-3,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
32,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,253J,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,전립선암세포주,CWR22,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,DLD-1,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,전립선암세포주,DU145,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,전립선암세포주,DU145/TXR,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,HCT 116,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,HCT-15,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,HCT-8,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,HL-60,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,Jurkat,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,KU-19-19,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,전립선암세포주,LNcap,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,흑색종,LOX-IMVI,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,MBT-2,0.90 μM,=,0.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,MIA PaCa-2,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,MOLT-4,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,MRC-5,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,MV-4-11,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,NCI-H12 99,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,NCI-H23,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,NCI-H460,1.78 μM,=,1.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,난소암,OVCAR-3,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,전립선암세포주,PC-3,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,RKO,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,Raji,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,유방암세포주,SK-BR-3,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,간암세포주,SK-HEP-1,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,대장암세포주,SW620,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,T24,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,뇌암세포주,U-251 MG,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
33,방광암세포주,UM-UC-3,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,DLD-1,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,전립선암세포주,DU145/TXR,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,HCT 116,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,HCT-15,1.95 μM,=,1.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,흑색종,LOX-IMVI,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,MIA PaCa-2,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,NCI-H12 99,2.00 μM,=,2.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,NCI-H23,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,난소암,OVCAR-3,0.99 μM,=,0.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,유방암세포주,SK-BR-3,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,간암세포주,SK-HEP-1,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,대장암세포주,SW620,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
34,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
35,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,MBT-2,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
36,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
37,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
38,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
39,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
40,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
41,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,DLD-1,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,NCI-H23,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,유방암세포주,SK-BR-3,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
42,방광암세포주,UM-UC-3,1.89 μM,=,1.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
43,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,253J,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,5637,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,A549,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,전립선암세포주,CWR22,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,DLD-1,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,전립선암세포주,DU145,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,전립선암세포주,DU145/TXR,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,Daudi,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,HCT 116,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,HCT-15,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,HCT-8,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,HL-60,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,J82,2.07 μM,=,2.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,Jurkat,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,KU-19-19,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,전립선암세포주,LNcap,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,흑색종,LOX-IMVI,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,MBT-2,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,MIA PaCa-2,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,MOLT-4,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,MRC-5,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,MV-4-11,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,NCI-H12 99,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,NCI-H23,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,NCI-H460,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,난소암,OVCAR-3,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,전립선암세포주,PC-3,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,RKO,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,Raji,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,Ramos (RA 1),1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,유방암세포주,SK-BR-3,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,간암세포주,SK-HEP-1,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,SW48 0,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,대장암세포주,SW620,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,T24,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,뇌암세포주,U-251 MG,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
44,방광암세포주,UM-UC-3,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
45,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,253J,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,5637,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,DLD-1,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,전립선암세포주,DU145/TXR,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,HCT 116,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,HCT-15,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,KU-19-19,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,흑색종,LOX-IMVI,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,MBT-2,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,MIA PaCa-2,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,NCI-H12 99,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,NCI-H23,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,난소암,OVCAR-3,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,RKO,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,유방암세포주,SK-BR-3,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,간암세포주,SK-HEP-1,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,대장암세포주,SW620,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,T24,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
46,방광암세포주,UM-UC-3,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
47,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,DLD-1,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,전립선암세포주,DU145/TXR,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,NCI-H23,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
48,방광암세포주,UM-UC-3,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
49,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,253J,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,5637,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,DLD-1,0.99 μM,=,0.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,전립선암세포주,DU145,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,전립선암세포주,DU145/TXR,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,HCT 116,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,HCT-15,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,HCT-8,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,Jurkat,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,KU-19-19,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,흑색종,LOX-IMVI,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,MBT-2,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,MIA PaCa-2,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,MOLT-4,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,NCI-H12 99,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,NCI-H23,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,난소암,OVCAR-3,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,전립선암세포주,PC-3,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,RKO,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,Raji,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,유방암세포주,SK-BR-3,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,간암세포주,SK-HEP-1,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,대장암세포주,SW620,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,T24,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,뇌암세포주,U-251 MG,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
50,방광암세포주,UM-UC-3,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,253J,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,5637,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,전립선암세포주,CWR22,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,DLD-1,0.66 μM,=,0.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,전립선암세포주,DU145,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,전립선암세포주,DU145/TXR,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,Daudi,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,HCT 116,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,HCT-15,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,HCT-8,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,HL-60,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,Jurkat,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,KU-19-19,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,전립선암세포주,LNcap,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,흑색종,LOX-IMVI,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,LoVo,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,MBT-2,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,MDA-MB-231,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,MIA PaCa-2,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,MOLT-4,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,MRC-5,0.58 μM,=,0.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,MV-4-11,0.68 μM,=,0.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,NCI-H12 99,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,NCI-H23,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,NCI-H460,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,폐암세포주,NCI-H522,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,난소암,OVCAR-3,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,전립선암세포주,PC-3,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,RKO,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,Raji,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,Ramos (RA 1),1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,유방암세포주,SK-BR-3,0.54 μM,=,0.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,간암세포주,SK-HEP-1,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,SW48 0,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,대장암세포주,SW620,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,T24,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,뇌암세포주,U-138 MG,1.92 μM,=,1.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,혈액암세포주,U-937,0.63 μM,=,0.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
51,방광암세포주,UM-UC-3,0.63 μM,=,0.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
52,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
53,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
54,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,253J,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,DLD-1,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,전립선암세포주,DU145/TXR,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,HCT 116,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,HCT-15,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,Jurkat,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,KU-19-19,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,흑색종,LOX-IMVI,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,MIA PaCa-2,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,MOLT-4,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,NCI-H23,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,난소암,OVCAR-3,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,전립선암세포주,PC-3,1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,유방암세포주,SK-BR-3,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,간암세포주,SK-HEP-1,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,대장암세포주,SW620,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,T24,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
55,방광암세포주,UM-UC-3,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,253J,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 56,Cytotoxicity (uM),253J,1.11,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,A549,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,전립선암세포주,CWR22,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,DLD-1,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,전립선암세포주,DU145,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,전립선암세포주,DU145/TXR,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,Daudi,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,HCC1954,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,HCT 116,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,HCT-15,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,HCT-8,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,HL-60,1.95 μM,=,1.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,J82,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,Jurkat,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,KU-19-19,0.90 μM,=,0.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 56,Cytotoxicity (uM),KU19-19,0.9,=,0.9,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,전립선암세포주,LNcap,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,흑색종,LOX-IMVI,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,MBT-2,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 56,Cytotoxicity (uM),MBT-2,1.18,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,MDA-M B-468,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,MDA-MB-231,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,MIA PaCa-2,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,MOLT-4,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,MRC-5,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,MV-4-11,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,NCI-H23,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,NCI-H460,1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,난소암,OVCAR-3,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,전립선암세포주,PC-3,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,RKO,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 56,Cytotoxicity (uM),RT4,> 10,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,Raji,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,Ramos (RA 1),1.86 μM,=,1.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,유방암세포주,SK-BR-3,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,간암세포주,SK-HEP-1,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,대장암세포주,SW620,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,T24,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,뇌암세포주,U-138 MG,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,뇌암세포주,U-251 MG,1.17 μM,=,1.17,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,혈액암세포주,U-937,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
56,방광암세포주,UM-UC-3,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 56,Cytotoxicity (uM),UM-UC-3,1.25,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,253J,1.92 μM,=,1.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,KU-19-19,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,NCI-H23,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,유방암세포주,SK-BR-3,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,T24,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
57,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,253J,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,전립선암세포주,CWR22,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,DLD-1,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,전립선암세포주,DU145,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,전립선암세포주,DU145/TXR,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,Daudi,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,HCT 116,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,HCT-15,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,HCT-8,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,HL-60,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,Jurkat,0.99 μM,=,0.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,KU-19-19,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,전립선암세포주,LNcap,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,흑색종,LOX-IMVI,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,LoVo,2.02 μM,=,2.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,MBT-2,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,MIA PaCa-2,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,MOLT-4,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,MRC-5,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,MV-4-11,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,NCI-H12 99,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,NCI-H23,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,폐암세포주,NCI-H522,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,난소암,OVCAR-3,0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,전립선암세포주,PC-3,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,RKO,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,Raji,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,Ramos (RA 1),1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,유방암세포주,SK-BR-3,0.62 μM,=,0.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,간암세포주,SK-HEP-1,0.78 μM,=,0.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,SW48 0,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,대장암세포주,SW620,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,T24,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,뇌암세포주,U-138 MG,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,뇌암세포주,U-251 MG,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,혈액암세포주,U-937,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
58,방광암세포주,UM-UC-3,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,253J,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,전립선암세포주,CWR22,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,DLD-1,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,전립선암세포주,DU145,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,전립선암세포주,DU145/TXR,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,HCT 116,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,HCT-15,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,HCT-8,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,HL-60,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,Jurkat,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,KU-19-19,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,흑색종,LOX-IMVI,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,MBT-2,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,MIA PaCa-2,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,MOLT-4,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,MRC-5,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,MV-4-11,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,NCI-H12 99,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,NCI-H23,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,NCI-H460,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,난소암,OVCAR-3,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,전립선암세포주,PC-3,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,RKO,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,Raji,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,유방암세포주,SK-BR-3,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,간암세포주,SK-HEP-1,0.91 μM,=,0.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,대장암세포주,SW620,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,T24,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,뇌암세포주,U-138 MG,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,뇌암세포주,U-251 MG,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
59,방광암세포주,UM-UC-3,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,253J,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,DLD-1,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,전립선암세포주,DU145/TXR,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,HCT 116,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,HCT-15,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,Jurkat,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,KU-19-19,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,흑색종,LOX-IMVI,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,MOLT-4,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,NCI-H23,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,전립선암세포주,PC-3,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,유방암세포주,SK-BR-3,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,T24,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
60,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
61,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
62,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,NCI-H23,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
63,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,253J,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,5637,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,전립선암세포주,CWR22,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,DLD-1,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,전립선암세포주,DU145,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,전립선암세포주,DU145/TXR,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,HCT 116,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,HCT-15,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,HCT-8,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,HL-60,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,J82,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,Jurkat,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,KU-19-19,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,전립선암세포주,LNcap,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,흑색종,LOX-IMVI,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,MBT-2,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,MIA PaCa-2,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,MOLT-4,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,MV-4-11,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,NCI-H12 99,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,NCI-H23,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,난소암,OVCAR-3,0.90 μM,=,0.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,전립선암세포주,PC-3,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,RKO,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,Raji,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,Ramos (RA 1),1.85 μM,=,1.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,유방암세포주,SK-BR-3,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,간암세포주,SK-HEP-1,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,대장암세포주,SW620,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,T24,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,뇌암세포주,U-138 MG,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
64,방광암세포주,UM-UC-3,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
65,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
66,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
67,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,253J,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,5637,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,A549,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,전립선암세포주,CWR22,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,DLD-1,0.78 μM,=,0.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,전립선암세포주,DU145,0.83 μM,=,0.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,전립선암세포주,DU145/TXR,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,Daudi,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,HCT 116,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,HCT-15,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,HCT-8,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,HL-60,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,HT-29,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,J82,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,Jurkat,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,KU-19-19,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,흑색종,LOX-IMVI,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,MBT-2,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,MDA-MB-231,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,MIA PaCa-2,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,MOLT-4,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,MRC-5,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,MV-4-11,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,NCI-H12 99,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,NCI-H23,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,NCI-H460,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,난소암,OVCAR-3,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,전립선암세포주,PC-3,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,RKO,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,Raji,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,Ramos (RA 1),1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,유방암세포주,SK-BR-3,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,간암세포주,SK-HEP-1,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,SW48 0,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,대장암세포주,SW620,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,T24,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,뇌암세포주,T98G,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,뇌암세포주,U-138 MG,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,뇌암세포주,U-251 MG,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
68,방광암세포주,UM-UC-3,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,253J,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,5637,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,A549,1.78 μM,=,1.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,전립선암세포주,CWR22,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,DLD-1,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,전립선암세포주,DU145,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,전립선암세포주,DU145/TXR,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,Daudi,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,HCT 116,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,HCT-15,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,HCT-8,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,HL-60,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,J82,1.89 μM,=,1.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,Jurkat,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,KU-19-19,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,흑색종,LOX-IMVI,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,MBT-2,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,MDA-MB-231,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,MIA PaCa-2,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,MOLT-4,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,MRC-5,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,MV-4-11,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,NCI-H12 99,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,NCI-H23,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,NCI-H460,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,난소암,OVCAR-3,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,전립선암세포주,PC-3,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,RKO,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,Raji,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,Ramos (RA 1),1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,유방암세포주,SK-BR-3,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,간암세포주,SK-HEP-1,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,대장암세포주,SW620,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,T24,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,뇌암세포주,U-138 MG,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,뇌암세포주,U-251 MG,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
69,방광암세포주,UM-UC-3,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,253J,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,5637,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,A549,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,전립선암세포주,CWR22,1.89 μM,=,1.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,DLD-1,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,전립선암세포주,DU145,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,전립선암세포주,DU145/TXR,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,Daudi,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,HCT 116,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,HCT-15,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,HCT-8,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,J82,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,Jurkat,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,KU-19-19,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,흑색종,LOX-IMVI,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,MBT-2,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,MIA PaCa-2,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,MOLT-4,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,MRC-5,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,MV-4-11,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,NCI-H12 99,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,NCI-H23,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,NCI-H460,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,난소암,OVCAR-3,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,전립선암세포주,PC-3,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,RKO,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,Raji,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,Ramos (RA 1),1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,유방암세포주,SK-BR-3,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,간암세포주,SK-HEP-1,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,대장암세포주,SW620,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,T24,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,뇌암세포주,U-138 MG,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,뇌암세포주,U-251 MG,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
70,방광암세포주,UM-UC-3,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,253J,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,5637,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,A549,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,DLD-1,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,전립선암세포주,DU145,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,전립선암세포주,DU145/TXR,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,HCT 116,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,HCT-15,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,J82,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,Jurkat,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,KU-19-19,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,흑색종,LOX-IMVI,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,MBT-2,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,MIA PaCa-2,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,MOLT-4,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,NCI-H12 99,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,NCI-H23,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,난소암,OVCAR-3,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,전립선암세포주,PC-3,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,Raji,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,유방암세포주,SK-BR-3,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,간암세포주,SK-HEP-1,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,T24,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
71,방광암세포주,UM-UC-3,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,253J,0.83 μM,=,0.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,5637,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,A549,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,AsPC-1,2.01 μM,=,2.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,전립선암세포주,CWR22,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,DLD-1,0.74 μM,=,0.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,DMS 114,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,전립선암세포주,DU145,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,전립선암세포주,DU145/TXR,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,Daudi,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,HCC1395,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,HCT 116,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,HCT-15,0.99 μM,=,0.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,HCT-8,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,HL-60,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,HT-29,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,J82,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,JIMT-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,Jurkat,0.78 μM,=,0.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,KU-19-19,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,전립선암세포주,LNcap,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,흑색종,LOX-IMVI,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,LoVo,1.92 μM,=,1.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,MBT-2,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,MDA-MB-231,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,MIA PaCa-2,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,MOLT-4,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,MRC-5,0.72 μM,=,0.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,MV-4-11,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,NCI-H12 99,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,NCI-H23,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,NCI-H460,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,난소암,OVCAR-3,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,전립선암세포주,PC-3,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,RKO,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,Raji,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,Ramos (RA 1),1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,유방암세포주,SK-BR-3,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,간암세포주,SK-HEP-1,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,SW48 0,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,대장암세포주,SW620,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,T24,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,뇌암세포주,U-138 MG,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,뇌암세포주,U-251 MG,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,혈액암세포주,U-937,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
72,방광암세포주,UM-UC-3,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,253J,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,DLD-1,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,전립선암세포주,DU145/TXR,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,HCT 116,1.86 μM,=,1.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,HL-60,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,흑색종,LOX-IMVI,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,MBT-2,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,MIA PaCa-2,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,MV-4-11,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,NCI-H23,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,난소암,OVCAR-3,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,전립선암세포주,PC-3,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,유방암세포주,SK-BR-3,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,간암세포주,SK-HEP-1,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,T24,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
73,방광암세포주,UM-UC-3,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,253J,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,5637,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,전립선암세포주,CWR22,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,DLD-1,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,전립선암세포주,DU145/TXR,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,HCT 116,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,HCT-15,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,HCT-8,2.01 μM,=,2.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,HL-60,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,KU-19-19,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,전립선암세포주,LNcap,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,흑색종,LOX-IMVI,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,MBT-2,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,MIA PaCa-2,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,MOLT-4,1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,MV-4-11,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,NCI-H12 99,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,NCI-H23,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,난소암,OVCAR-3,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,전립선암세포주,PC-3,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,유방암세포주,SK-BR-3,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,간암세포주,SK-HEP-1,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,대장암세포주,SW620,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,T24,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,뇌암세포주,U-138 MG,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
74,방광암세포주,UM-UC-3,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,253J,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,5637,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,A549,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,전립선암세포주,CWR22,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,DLD-1,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,전립선암세포주,DU145,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,전립선암세포주,DU145/TXR,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,Daudi,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,HCC1395,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,HCT 116,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,HCT-15,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,HCT-8,1.78 μM,=,1.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,J82,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,JIMT-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,Jurkat,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,KU-19-19,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,흑색종,LOX-IMVI,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,MBT-2,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,MDA-MB-231,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,MIA PaCa-2,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,MOLT-4,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,MRC-5,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,NCI-H12 99,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,NCI-H23,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,NCI-H460,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,난소암,OVCAR-3,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,전립선암세포주,PC-3,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,RKO,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,Raji,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,유방암세포주,SK-BR-3,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,간암세포주,SK-HEP-1,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,SW48 0,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,대장암세포주,SW620,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,T24,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,뇌암세포주,U-138 MG,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,뇌암세포주,U-251 MG,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
75,방광암세포주,UM-UC-3,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,253J,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,DLD-1,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,전립선암세포주,DU145,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,전립선암세포주,DU145/TXR,1.17 μM,=,1.17,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,Daudi,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,HCT 116,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,HCT-15,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,Jurkat,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,KU-19-19,1.86 μM,=,1.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,흑색종,LOX-IMVI,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,MBT-2,1.86 μM,=,1.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,MIA PaCa-2,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,MOLT-4,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,MRC-5,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,NCI-H12 99,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,NCI-H23,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,난소암,OVCAR-3,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,전립선암세포주,PC-3,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,RKO,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,Raji,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,유방암세포주,SK-BR-3,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,간암세포주,SK-HEP-1,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,T24,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
76,방광암세포주,UM-UC-3,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,253J,0.90 μM,=,0.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,5637,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,A549,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,DLD-1,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,전립선암세포주,DU145,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,전립선암세포주,DU145/TXR,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,Daudi,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,HCT 116,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,HCT-15,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,HCT-8,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,J82,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,Jurkat,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,KU-19-19,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,흑색종,LOX-IMVI,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,MBT-2,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,MIA PaCa-2,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,MOLT-4,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,MRC-5,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,NCI-H12 99,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,NCI-H23,0.96 μM,=,0.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,NCI-H460,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,난소암,OVCAR-3,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,전립선암세포주,PC-3,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,RKO,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,Raji,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,유방암세포주,SK-BR-3,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,간암세포주,SK-HEP-1,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,SW48 0,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,대장암세포주,SW620,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,T24,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,뇌암세포주,T98G,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,뇌암세포주,U-138 MG,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,뇌암세포주,U-251 MG,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
77,방광암세포주,UM-UC-3,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,253J,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,DLD-1,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,전립선암세포주,DU145,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,전립선암세포주,DU145/TXR,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,HCT 116,1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,HCT-15,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,흑색종,LOX-IMVI,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,MBT-2,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,MIA PaCa-2,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,MRC-5,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,NCI-H12 99,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,NCI-H23,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,난소암,OVCAR-3,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,전립선암세포주,PC-3,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,RKO,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,Ramos (RA 1),1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,유방암세포주,SK-BR-3,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,간암세포주,SK-HEP-1,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,대장암세포주,SW620,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,T24,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
78,방광암세포주,UM-UC-3,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
79,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
80,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
81,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,신경아세포종,SH-SY5Y,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,유방암세포주,SK-BR-3,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
82,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,253J,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,5637,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,전립선암세포주,CWR22,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,DLD-1,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,전립선암세포주,DU145,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,전립선암세포주,DU145/TXR,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,Daudi,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,HCC1954,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,HCT 116,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,HCT-15,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,HCT-8,1.88 μM,=,1.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,Jurkat,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,KU-19-19,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,흑색종,LOX-IMVI,1.57 μM,=,1.57,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,MBT-2,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,MDA-M B-468,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,MDA-MB-231,1.95 μM,=,1.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,MIA PaCa-2,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,MOLT-4,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,MRC-5,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,NCI-H12 99,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,NCI-H23,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,NCI-H460,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,난소암,OVCAR-3,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,RKO,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,Raji,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,Ramos (RA 1),1.17 μM,=,1.17,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,신경아세포종,SH-SY5Y,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,유방암세포주,SK-BR-3,1.21 μM,=,1.21,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,간암세포주,SK-HEP-1,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,T24,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,뇌암세포주,T98G,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,뇌암세포주,U-251 MG,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
83,방광암세포주,UM-UC-3,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,253J,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,신장암,ACHN,1.3765,=,1.3765,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,AsPC-1,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,전립선암세포주,CWR22,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,Capan-1,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,DLD-1,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,전립선암세포주,DU145,1.39 μM,=,1.39,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,전립선암세포주,DU145/TXR,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,Daudi,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,HCC1954,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,HCT 116,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,HCT-15,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,HCT-8,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,HL-60,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,Jurkat,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,KU-19-19,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,흑색종,LOX-IMVI,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,LoVo,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,MBT-2,0.67 μM,=,0.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,MDA-M B-468,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,MDA-MB-231,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,MIA PaCa-2,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,MOLT-4,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,MRC-5,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,MV-4-11,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,NCI-H12 99,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,NCI-H23,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,NCI-H460,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,폐암세포주,NCI-H522,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,난소암,OVCAR-3,0.59 μM,=,0.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,RKO,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,Raji,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,Ramos (RA 1),1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,신경아세포종,SH-SY5Y,0.60 μM,=,0.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,유방암세포주,SK-BR-3,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,간암세포주,SK-HEP-1,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,SW48 0,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,대장암세포주,SW620,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,T24,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,혈액암세포주,U-937,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
84,방광암세포주,UM-UC-3,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
85,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,253J,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,5637,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,A549,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,신장암,ACHN,1.3337,=,1.3337,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,AsPC-1,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,전립선암세포주,CWR22,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,Capan-1,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,DLD-1,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,전립선암세포주,DU145,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,전립선암세포주,DU145/TXR,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,Daudi,0.65 μM,=,0.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,HCC1954,0.50 μM,=,0.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,HCT 116,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,HCT-15,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,HCT-8,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,HL-60,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,J82,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,Jurkat,0.55 μM,=,0.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,KU-19-19,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,흑색종,LOX-IMVI,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,LoVo,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,MBT-2,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,MCF7,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,MDA-M B-468,0.58 μM,=,0.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,MDA-MB-231,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,MDA-MB-231 -L/DOX,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,MIA PaCa-2,0.64 μM,=,0.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,MOLT-4,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,MRC-5,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,MV-4-11,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,NCI-H12 99,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,NCI-H1437,< 2 μM,<,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,NCI-H23,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,NCI-H460,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,폐암세포주,NCI-H522,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,난소암,OVCAR-3,0.38 μM,=,0.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,전립선암세포주,PC-3,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,RKO,0.89 μM,=,0.89,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,Raji,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,Ramos (RA 1),0.46 μM,=,0.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,신경아세포종,SH-SY5Y,0.50 μM,=,0.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,유방암세포주,SK-BR-3,0.58 μM,=,0.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,간암세포주,SK-HEP-1,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,SW48 0,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,대장암세포주,SW620,0.74 μM,=,0.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,T24,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,뇌암세포주,U-138 MG,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,뇌암세포주,U-251 MG,0.74 μM,=,0.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,혈액암세포주,U-937,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
86,방광암세포주,UM-UC-3,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
87,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,신경아세포종,SH-SY5Y,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
88,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,253J,1.84 μM,=,1.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,DLD-1,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,전립선암세포주,DU145/TXR,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,HCC1954,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,HCT 116,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,Jurkat,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,흑색종,LOX-IMVI,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,MBT-2,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,MDA-M B-468,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,MIA PaCa-2,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,MV-4-11,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,NCI-H23,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,난소암,OVCAR-3,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,RKO,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,Ramos (RA 1),1.71 μM,=,1.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,신경아세포종,SH-SY5Y,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,유방암세포주,SK-BR-3,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,간암세포주,SK-HEP-1,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,대장암세포주,SW620,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,T24,1.75 μM,=,1.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
89,방광암세포주,UM-UC-3,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
90,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,DLD-1,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,전립선암세포주,DU145/TXR,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,HCC1954,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,Jurkat,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,MBT-2,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,MDA-M B-468,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,MIA PaCa-2,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,NCI-H23,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,난소암,OVCAR-3,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,RKO,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,신경아세포종,SH-SY5Y,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,유방암세포주,SK-BR-3,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,간암세포주,SK-HEP-1,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
91,방광암세포주,UM-UC-3,1.56 μM,=,1.56,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
92,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
93,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,자궁경부암,HeLa,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,MBT-2,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,MDA-M B-468,1.85 μM,=,1.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,MIA PaCa-2,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,MV-4-11,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,NCI-H23,2.07 μM,=,2.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,난소암,OVCAR-3,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,신경아세포종,SH-SY5Y,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,유방암세포주,SK-BR-3,1.85 μM,=,1.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
94,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,253J,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,5637,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,A549,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,신장암,ACHN,1.1911,=,1.1911,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,AsPC-1,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,BT-20,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,전립선암세포주,CWR22,1.08 μM,=,1.08,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,Capan-1,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,DLD-1,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,전립선암세포주,DU145,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,전립선암세포주,DU145/TXR,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,Daudi,0.64 μM,=,0.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,HCC1954,0.48 μM,=,0.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,HCT 116,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,HCT-15,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,HCT-8,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,HL-60,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,J82,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,JIMT-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,Jurkat,0.29 μM,=,0.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,KU-19-19,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,전립선암세포주,LNcap,1.98 μM,=,1.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,흑색종,LOX-IMVI,0.54 μM,=,0.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,LoVo,0.91 μM,=,0.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,MBT-2,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,MCF7,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,MDA-M B-468,0.47 μM,=,0.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,MDA-MB-231,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,MDA-MB-231 -L/DOX,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,MIA PaCa-2,0.59 μM,=,0.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,MOLT-4,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,MRC-5,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,MV-4-11,0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,NCI-H12 99,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,NCI-H1437,< 2 μM,<,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,NCI-H23,0.72 μM,=,0.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,NCI-H460,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,폐암세포주,NCI-H522,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,난소암,OVCAR-3,0.38 μM,=,0.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,전립선암세포주,PC-3,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,RKO,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,Raji,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,Ramos (RA 1),0.52 μM,=,0.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,신경아세포종,SH-SY5Y,0.48 μM,=,0.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,유방암세포주,SK-BR-3,0.47 μM,=,0.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,간암세포주,SK-HEP-1,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,SW48 0,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,대장암세포주,SW620,0.64 μM,=,0.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,T24,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,뇌암세포주,U-138 MG,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,뇌암세포주,U-251 MG,0.61 μM,=,0.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,혈액암세포주,U-937,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
95,방광암세포주,UM-UC-3,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,253J,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,신장암,ACHN,1.6698,=,1.6698,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,전립선암세포주,CWR22,1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,DLD-1,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,전립선암세포주,DU145,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,전립선암세포주,DU145/TXR,1.77 μM,=,1.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,Daudi,1.37 μM,=,1.37,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,HCC1954,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,HCT 116,1.53 μM,=,1.53,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,HCT-15,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,HL-60,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,Jurkat,0.59 μM,=,0.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,MBT-2,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,MDA-M B-468,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,MIA PaCa-2,1.14 μM,=,1.14,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,MRC-5,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,MV-4-11,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,NCI-H12 99,1.80 μM,=,1.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,NCI-H23,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,폐암세포주,NCI-H522,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,난소암,OVCAR-3,0.75 μM,=,0.75,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,RKO,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,Raji,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,Ramos (RA 1),1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,신경아세포종,SH-SY5Y,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,유방암세포주,SK-BR-3,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,간암세포주,SK-HEP-1,1.96 μM,=,1.96,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,대장암세포주,SW620,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,T24,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,뇌암세포주,U-251 MG,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
96,방광암세포주,UM-UC-3,1.63 μM,=,1.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,253J,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,5637,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,신장암,ACHN,1.3287,=,1.3287,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,AsPC-1,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,전립선암세포주,CWR22,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,Capan-1,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,DLD-1,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,전립선암세포주,DU145,1.28 μM,=,1.28,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,전립선암세포주,DU145/TXR,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,Daudi,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,HCC1954,0.78 μM,=,0.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,HCT 116,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,HCT-15,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,HCT-8,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,Jurkat,0.51 μM,=,0.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,KU-19-19,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,흑색종,LOX-IMVI,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,LoVo,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,MBT-2,0.81 μM,=,0.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,MDA-M B-468,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,MDA-MB-231,1.78 μM,=,1.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,MDA-MB-231 -L/DOX,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,MIA PaCa-2,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,MOLT-4,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,MRC-5,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,MV-4-11,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,NCI-H12 99,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,NCI-H23,1.09 μM,=,1.09,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,NCI-H460,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,폐암세포주,NCI-H522,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,난소암,OVCAR-3,0.59 μM,=,0.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,전립선암세포주,PC-3,1.70 μM,=,1.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,RKO,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,Raji,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,Ramos (RA 1),0.70 μM,=,0.70,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,신경아세포종,SH-SY5Y,0.60 μM,=,0.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,유방암세포주,SK-BR-3,0.76 μM,=,0.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,간암세포주,SK-HEP-1,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,SW48 0,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,대장암세포주,SW620,1.10 μM,=,1.10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,T24,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,뇌암세포주,U-138 MG,1.69 μM,=,1.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,뇌암세포주,U-251 MG,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,혈액암세포주,U-937,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
97,방광암세포주,UM-UC-3,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,253J,1.38 μM,=,1.38,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,신장암,ACHN,1.8121,=,1.8121,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,전립선암세포주,CWR22,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,DLD-1,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,전립선암세포주,DU145,1.92 μM,=,1.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,전립선암세포주,DU145/TXR,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,Daudi,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,HCC1954,1.31 μM,=,1.31,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,HCT 116,1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,HCT-15,1.73 μM,=,1.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,HCT-8,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,Jurkat,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,KU-19-19,1.90 μM,=,1.90,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,흑색종,LOX-IMVI,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,MBT-2,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,MDA-M B-468,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,MDA-MB-231,1.86 μM,=,1.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,MIA PaCa-2,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,MV-4-11,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,NCI-H12 99,1.81 μM,=,1.81,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,NCI-H23,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,NCI-H460,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,난소암,OVCAR-3,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,RKO,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,Ramos (RA 1),1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,신경아세포종,SH-SY5Y,0.83 μM,=,0.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,유방암세포주,SK-BR-3,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,간암세포주,SK-HEP-1,1.20 μM,=,1.20,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,대장암세포주,SW620,1.76 μM,=,1.76,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,T24,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,뇌암세포주,U-251 MG,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
98,방광암세포주,UM-UC-3,1.52 μM,=,1.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,253J,0.80 μM,=,0.80,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 99,Cytotoxicity (uM),253J,0.8,=,0.8,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,5637,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,A549,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,신장암,ACHN,1.206,=,1.206,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,AsPC-1,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,전립선암세포주,CWR22,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,Capan-1,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,DLD-1,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,전립선암세포주,DU145,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,전립선암세포주,DU145/TXR,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,Daudi,1.00 μM,=,1.00,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,HCC1395,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,HCC1954,0.78 μM,=,0.78,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,HCT 116,0.82 μM,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,HCT-15,0.97 μM,=,0.97,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,HCT-8,0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,J82,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,Jurkat,0.44 μM,=,0.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,KU-19-19,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 99,Cytotoxicity (uM),KU19-19,1.12,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,흑색종,LOX-IMVI,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,LoVo,1.45 μM,=,1.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,MBT-2,0.47 μM,=,0.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 99,Cytotoxicity (uM),MBT-2,0.47,=,0.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,MDA-M B-468,0.67 μM,=,0.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,MDA-MB-231,1.17 μM,=,1.17,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,MIA PaCa-2,0.72 μM,=,0.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,MOLT-4,0.73 μM,=,0.73,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,MRC-5,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,MV-4-11,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,NCI-H12 99,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,NCI-H23,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,NCI-H460,1.18 μM,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,폐암세포주,NCI-H522,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,난소암,OVCAR-3,0.63 μM,=,0.63,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,전립선암세포주,PC-3,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,RKO,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 99,Cytotoxicity (uM),RT4,> 10,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,Raji,1.25 μM,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,Ramos (RA 1),0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,신경아세포종,SH-SY5Y,0.45 μM,=,0.45,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,유방암세포주,SK-BR-3,0.67 μM,=,0.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,간암세포주,SK-HEP-1,1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,SW48 0,1.30 μM,=,1.30,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,대장암세포주,SW620,0.92 μM,=,0.92,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,T24,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,뇌암세포주,U-138 MG,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,뇌암세포주,U-251 MG,0.79 μM,=,0.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,혈액암세포주,U-937,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
99,방광암세포주,UM-UC-3,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
화합물 99,Cytotoxicity (uM),UM-UC-3,0.77,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
100,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,253J,1.82 μM,=,1.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,전립선암세포주,DU145,1.34 μM,=,1.34,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,전립선암세포주,DU145/TXR,1.42 μM,=,1.42,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,Daudi,1.04 μM,=,1.04,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,HCC1954,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,HCT 116,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,HCT-8,1.61 μM,=,1.61,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,Jurkat,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,MDA-M B-468,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,MIA PaCa-2,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,MOLT-4,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,NCI-H23,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,난소암,OVCAR-3,1.99 μM,=,1.99,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,RKO,1.91 μM,=,1.91,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,Raji,1.79 μM,=,1.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,Ramos (RA 1),1.48 μM,=,1.48,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,신경아세포종,SH-SY5Y,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,유방암세포주,SK-BR-3,1.67 μM,=,1.67,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
101,방광암세포주,UM-UC-3,1.93 μM,=,1.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,253J,0.83 μM,=,0.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,A549,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,신장암,ACHN,1.6277,=,1.6277,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,AsPC-1,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,전립선암세포주,CWR22,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,Capan-1,1.66 μM,=,1.66,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,DLD-1,1.16 μM,=,1.16,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,전립선암세포주,DU145,1.65 μM,=,1.65,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,전립선암세포주,DU145/TXR,1.12 μM,=,1.12,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,Daudi,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,HCC1954,1.02 μM,=,1.02,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,HCT 116,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,HCT-15,1.33 μM,=,1.33,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,HCT-8,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,HL-60,1.87 μM,=,1.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,KU-19-19,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,흑색종,LOX-IMVI,0.86 μM,=,0.86,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,LoVo,1.94 μM,=,1.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,MBT-2,0.77 μM,=,0.77,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,MDA-M B-468,1.35 μM,=,1.35,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,MDA-MB-231,1.72 μM,=,1.72,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,MIA PaCa-2,0.69 μM,=,0.69,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,MOLT-4,0.94 μM,=,0.94,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,MRC-5,1.43 μM,=,1.43,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,MV-4-11,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,NCI-H12 99,1.11 μM,=,1.11,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,NCI-H23,1.26 μM,=,1.26,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,NCI-H460,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,폐암세포주,NCI-H522,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,난소암,OVCAR-3,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,전립선암세포주,PC-3,1.83 μM,=,1.83,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,RKO,1.19 μM,=,1.19,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,Raji,1.40 μM,=,1.40,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,Ramos (RA 1),0.98 μM,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,신경아세포종,SH-SY5Y,0.52 μM,=,0.52,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,유방암세포주,SK-BR-3,0.85 μM,=,0.85,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,SW48 0,1.60 μM,=,1.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,대장암세포주,SW620,1.22 μM,=,1.22,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,T24,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,뇌암세포주,U-138 MG,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
102,방광암세포주,UM-UC-3,1.07 μM,=,1.07,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,신경아세포종,SH-SY5Y,1.01 μM,=,1.01,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,유방암세포주,SK-BR-3,1.74 μM,=,1.74,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,뇌암세포주,U-138 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
103,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,253J,0.87 μM,=,0.87,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,A549,1.68 μM,=,1.68,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,신장암,ACHN,1.1984,=,1.1984,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,전립선암세포주,CWR22,1.55 μM,=,1.55,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,Capan-1,1.59 μM,=,1.59,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,DLD-1,1.24 μM,=,1.24,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,전립선암세포주,DU145,1.64 μM,=,1.64,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,전립선암세포주,DU145/TXR,1.23 μM,=,1.23,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,Daudi,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,HCC1954,1.05 μM,=,1.05,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,HCT 116,1.32 μM,=,1.32,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,HCT-15,1.49 μM,=,1.49,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,HCT-8,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,KU-19-19,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,흑색종,LOX-IMVI,0.88 μM,=,0.88,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,MBT-2,0.71 μM,=,0.71,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,MDA-M B-468,1.46 μM,=,1.46,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,MDA-MB-231,1.54 μM,=,1.54,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,MIA PaCa-2,0.79 μM,=,0.79,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,MOLT-4,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,MRC-5,1.62 μM,=,1.62,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,MV-4-11,0.95 μM,=,0.95,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,NCI-H12 99,1.17 μM,=,1.17,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,NCI-H23,1.27 μM,=,1.27,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,NCI-H460,1.51 μM,=,1.51,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,폐암세포주,NCI-H522,1.41 μM,=,1.41,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,난소암,OVCAR-3,0.84 μM,=,0.84,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,RKO,1.15 μM,=,1.15,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,Raji,1.44 μM,=,1.44,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,Ramos (RA 1),1.06 μM,=,1.06,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,신경아세포종,SH-SY5Y,0.60 μM,=,0.60,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,유방암세포주,SK-BR-3,0.93 μM,=,0.93,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,간암세포주,SK-HEP-1,1.50 μM,=,1.50,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,SW48 0,1.58 μM,=,1.58,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,대장암세포주,SW620,1.36 μM,=,1.36,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,T24,1.03 μM,=,1.03,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,뇌암세포주,U-138 MG,1.47 μM,=,1.47,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
104,방광암세포주,UM-UC-3,1.13 μM,=,1.13,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
105,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,신경아세포종,SH-SY5Y,1.29 μM,=,1.29,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
106,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,253J,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,5637,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,A549,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,신장암,ACHN,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,AsPC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,BT-20,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,BxPC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,CFPAC-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,전립선암세포주,CWR22,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,Capan-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,Capan-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,DLD-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,DMS 114,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,전립선암세포주,DU145,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,전립선암세포주,DU145/TXR,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,Daudi,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,HCC1395,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,HCC1954,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,HCT 116,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,HCT-15,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,HCT-8,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,HL-60,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,HT-29,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,자궁경부암,HeLa,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,J82,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,JIMT-1,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,Jurkat,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,KU-19-19,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,전립선암세포주,LNcap,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,흑색종,LOX-IMVI,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,LoVo,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,MBT-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,MCF7,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,MDA-M B-468,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,MDA-MB-231,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,MDA-MB-231 -L/DOX,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,MIA PaCa-2,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,MOLT-4,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,MRC-5,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,MV-4-11,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,NCI-H12 99,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,NCI-H1437,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,NCI-H23,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,NCI-H460,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,폐암세포주,NCI-H522,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,난소암,OVCAR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,췌장암세포주,PANC-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,전립선암세포주,PC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,RKO,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유두종(papilloma),RT4,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,Raji,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,Ramos (RA 1),> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,신경아세포종,SH-SY5Y,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,유방암세포주,SK-BR-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,간암세포주,SK-HEP-1,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,SW48 0,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,대장암세포주,SW620,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,T24,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,뇌암세포주,T98G,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,뇌암세포주,U-138 MG,> 10 μM,>,10,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,뇌암세포주,U-251 MG,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,혈액암세포주,U-937,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
107,방광암세포주,UM-UC-3,> 2 μM,>,2,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
KSI-3716,Cytotoxicity (uM),253J,0.98,=,0.98,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
KSI-3716,Cytotoxicity (uM),KU19-19,0.82,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
KSI-3716,Cytotoxicity (uM),MBT-2,1.18,=,1.18,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
KSI-3716,Cytotoxicity (uM),RT4,1.25,=,1.25,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
KSI-3716,Cytotoxicity (uM),UM-UC-3,0.82,=,0.82,uM,../base/data/bronze/artifacts/2017_raw.xlsx,표5~표14,
